Skip to main content
LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.310
+0.080 (6.50%)
Apr 17, 2025, 4:00 PM EDT - Market closed

LAVA Therapeutics Revenue

In the year 2024, LAVA Therapeutics had annual revenue of $11.98M with 77.01% growth. LAVA Therapeutics had revenue of $4.99M in the quarter ending December 31, 2024, with 1,313.60% growth.

Revenue (ttm)
$11.98M
Revenue Growth
+77.01%
P/S Ratio
2.93
Revenue / Employee
$352,412
Employees
34
Market Cap
34.46M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202411.98M5.21M77.01%
Dec 31, 20236.77M-12.62M-65.09%
Dec 31, 202219.39M14.04M262.45%
Dec 31, 20215.35M1.60M42.78%
Dec 31, 20203.75M--
Jan 1, 2020 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

LVTX News

More News